Mechanism of Action
T4 (four iodine atoms on tyrosine) is largely inactive. Converted to T3 (three iodine atoms) by selenoenzyme deiodinases in liver, kidney, and peripheral tissues. This conversion step makes T4 slower acting and more stable than T3. Downstream mechanism identical to T3 — thyroid hormone receptor activation, metabolic rate regulation.
Ester Profile
Not a steroid. No ester. Oral tablet — synthetic levothyroxine. Long half-life of approximately 7 days due to significant plasma protein binding. Stable blood levels with once-daily dosing.
How It's Used in Fitness
T4 is less commonly used in performance settings than T3 because it requires conversion to the active hormone before producing effects, making the onset slower and the dose-response relationship less predictable. Some athletes prefer it for this reason: the conversion step provides a buffer that makes acute overdose effects less likely. It is used for the same metabolic acceleration goals as T3, particularly during extended cutting phases where the goal is sustained metabolic rate maintenance rather than rapid acute fat loss. It is also used by athletes who have suppressed their endogenous thyroid function through previous T3 use and are attempting to normalize function.
Stacking Context
T4 is sometimes used in place of T3 in fat loss stacks, particularly in extended prep phases where the slower onset and less acute action is preferred. It appears in the same types of stacks as T3: alongside Clenbuterol for metabolic acceleration and within anabolic protocols that include muscle-sparing compounds to offset catabolism. It is occasionally combined with low-dose T3 to provide both the rapid action of the active hormone and the sustained background elevation from the prohormone form.
Medical Use
- Hypothyroidism — most commonly prescribed thyroid medication globally
- TSH suppression in thyroid cancer follow-up
- Goiter treatment
- Combination with T3 in some refractory cases
Side Effects
- Thyroid axis suppression — TSH suppression with chronic exogenous use
- Cardiac effects — arrhythmias, tachycardia at supraphysiological levels
- Bone density reduction with chronic supraphysiological dosing
- Anxiety, nervousness, tremors
- Weight loss — can be excessive at non-physiological doses
- Slower onset than T3 — effects take days to weeks to manifest
What Actually Goes Wrong
The risks are similar to T3 with the addition of variability in conversion efficiency. Some individuals convert T4 to T3 more efficiently than others, and stress, nutritional deficiencies, and certain medications can impair conversion, creating unpredictable results from a fixed dose. The thyroid suppression risk is the same as with T3. The fact that T4 is the most commonly prescribed medication in the world for hypothyroidism leads some users to underestimate the risk, reasoning that if millions of people take it safely it must be inherently safe. The distinction between replacing a deficient hormone and adding a hormone that is already at normal levels is fundamental to understanding why that reasoning is flawed.
Detection Window
Similar challenges to T3 detection — endogenous hormone. TSH suppression is primary detection marker.
T4 as a performance compound is a less common and less discussed choice than T3, which sometimes gives it a false appearance of being the safer or more conservative option. The fundamental risk is the same: you are adding exogenous thyroid hormone to a system that is already producing it, which suppresses that natural production over time. The conversion step does not eliminate risk, it just changes the pharmacokinetics.